Share the post "Zenotech Laboratories Limited’s Quarterly Result and Earnings Report for Q4(Mar 2024) : Sales decreased by 18.74 % in YoY and decreased by 26.06 % in QoQ"
Highlights
- Sales over the Year and quarter: The company’s sales declined by -18.74 % over the year, decrease in net sales/revenue by -26.06 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 7.2 %. Marginal increase in other income during this quarter, up by 378.57%.
- Profit over the Year and quarter: Challenges in sustaining profitability for Zenotech Laboratories Limited. Profit dropped by -82.01 % Year to Year, Zenotech Laboratories Limited’s profitability dropped by -80.36 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -81.67 % Year to Year. EPS decreased by -80 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 9.956 Cr | Rs. 10.942 Cr | Rs. 8.09 Cr | -26.06 % | -18.74 % |
| Expenses | Rs. 5.94 Cr | Rs. 5.68 Cr | Rs. 6.33 Cr | + 11.44 % | + 6.57 % |
| Operating Profit | Rs. 4.02 Cr | Rs. 5.26 Cr | Rs. 1.76 Cr | -66.54 % | -56.22 % |
| OPM % | 40.38 % | 48.07 % | 21.76 % | -26.31 % | -18.62 % |
| Other Income | Rs. 1.25 Cr | Rs. 0.28 Cr | Rs. 1.34 Cr | + 378.57 % | + 7.2 % |
| Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | + 0 % |
| Depreciation | Rs. 1.78 Cr | Rs. 1.74 Cr | Rs. 1.73 Cr | -0.57 % | -2.81 % |
| Profit before tax | Rs. 3.49 Cr | Rs. 3.8 Cr | Rs. 1.37 Cr | -63.95 % | -60.74 % |
| Tax % | 5.31 % | 11.65 % | 51.93 % | + 40.28 % | + 46.62 % |
| Net Profit | Rs. 3.67 Cr | Rs. 3.36 Cr | Rs. 0.66 Cr | -80.36 % | -82.02 % |
| EPS in Rs | Rs. 0.6 | Rs. 0.55 | Rs. 0.11 | -80 % | -81.67 % |
Today, we’re looking at Zenotech Laboratories Limited’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -18.74 %. However, it did see a marginal slip of -26.06 % from the previous quarter. Expenses ticked up slightly by 11.44 % quarter-on-quarter, aligning with the annual rise of 6.57 %. Operating profit, while down -56.22 % compared to last year, faced a quarter-on-quarter dip of -66.54 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -18.62 %, but a shrinkage of -26.31 % sequentially. Other income rose by 378.57 % compared to the last quarter, despite an annual growth of 7.2 %. Interest expenses dropped significantly by -10.53 % from the previous quarter, yet the year-over-year increase remains at a moderate 0 %. Depreciation costs fell by -0.57 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -2.81 %. Profit before tax declined annually by -60.74 % but saw a reduction from the preceding quarter by -63.95 %.
Tax expenses as a percentage of profits increased slightly by 46.62 % compared to last year, with a more notable quarter-on-quarter increase of 40.28 %. Net profit fell by -82.02 % year-on-year but witnessed a -80.36 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -81.67 % but a quarterly fall of -80 %. In summary, Zenotech Laboratories Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 9.956 Cr | Rs. 10.942 Cr | Rs. 8.09 Cr | -26.06 % | -18.74 % |
| Expenses | Rs. 5.94 Cr | Rs. 5.68 Cr | Rs. 6.33 Cr | + 11.44 % | + 6.57 % |
| Operating Profit | Rs. 4.02 Cr | Rs. 5.26 Cr | Rs. 1.76 Cr | -66.54 % | -56.22 % |
| Net Profit | Rs. 3.67 Cr | Rs. 3.36 Cr | Rs. 0.66 Cr | -80.36 % | -82.02 % |
| EPS in Rs | Rs. 0.6 | Rs. 0.55 | Rs. 0.11 | -80 % | -81.67 % |
In reviewing Zenotech Laboratories Limited’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -18.74 % year-on-year, although there was a slight dip of -26.06 % from the previous quarter. Expenses rose by 6.57 % compared to the previous year, with a 11.44 % increase quarter-on-quarter. Operating Profit dropped by -56.22 % annually, and saw a -66.54 % decrease from the last quarter.
Net Profit showed yearly decrease of -82.02 %, and experienced a -80.36 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -81.67 % annually, however dipped by -80 % compared to the last quarter. In essence, while Zenotech Laboratories Limited faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
